ATLANTA, Georgia, July 25 -- Emory University's Woodruff Health Sciences Center issued the following news release: An experimental gene-silencing drug designed for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a clinical trial conducted at the Emory ALS Center and other medical centers around the world. The trial indicated that the "antisense" drug, known as tofersen, lowers levels of a disease-causing protein in people with a type of ALS caused by mutation  more

HOLYOKE, Massachusetts, July 25 -- ISO New England issued the following news release: In its first-ever competitive process for transmission development, ISO New England has narrowed its selection to one proposal to address the region's power system reliability needs resulting from the scheduled retirement of the Mystic Generating Station in 2024. The Greater Boston Ready Path solution, a joint venture of National Grid and Eversource, has emerged from a field of 36 proposals based on its abilit  more

LA JOLLA, California, July 24 -- The University of California San Diego campus issued the following news: UC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19. The trial, sponsored by the National Institutes of Health's (NIH) newly f  more